Insilico
The deal grants Lilly exclusive global rights to use Insilico's Pharma.AI platform for drug discovery and development across multiple therapeutic areas.
The funds will be used to advance Insilico's drug pipeline and lab, which automates the research and development process, and refine its AI-enabled models and algorithms.
The partnership highlights the broader trend of AI-driven innovation in drug discovery and precision medicine.
Also: Drug discovery platform Insilico Medicine raises $60 million, Women's virtual care startup Visana Health brings in $2.6 million and digital reproductive care clinic Choix scoops up $1 million.
The company plans to use this money to use its therapeutics program in human clinical trials.